Switzerland· 68860003
Candesartan Amlodipin Sandoz
A candesartan und amlodipin product containing candesartanum cilexetilum, amlodipinum, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 6 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Candesartan und amlodipin is registered in 6 of 19 countries.
Countries holding a registration under ATC C09DB07 (candesartan und amlodipin), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 6 of them publish a price we can compare per daily dose
Candesartan und amlodipin · ATC C09DB07
6 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Italyprice
- Polandprice
- Switzerlandprice
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Active substance
- candesartanum cilexetilum, amlodipinum
- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- C09DB07
- ATC class
- Candesartan und Amlodipin
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680688600032Blist 28 StkCHF 35.95
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
8 interactions on record for candesartan und amlodipin.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Candesartan und amlodipin · interactions on record
8 records
8 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Candesartan und amlodipin in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d7aab121-24ef-4e4b-8ab2-57736bd70c3d GET /v1/drugs/d7aab121-24ef-4e4b-8ab2-57736bd70c3d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "candesartanum cilexetilum 8 mg + amlodipinum 10 mg",
"valid_from": "2024-12-01",
"limitations": "[{\"description\":\"Die gleichzeitige Therapie mit einer Fixkombination aus Candesartan und Amlodipin und einem Calciumantagonisten des I.T. 02.06. und/oder einem Angiotensin-II-Antagonisten und/oder einem ACE-Hemmer wird von der obligatorischen Krankenpflegeversicherung nicht vergütet.\",\"costApproval\":null,\"indication\":\"21664.01\",\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2025-10-01\",\"validTo\":null}]",
"galenic_form": "Kaps 8/10mg",
"therapeutic_area": null,
"sl_inclusion_date": "2024-12-01",
"self_retention_pct": 10
}See everything about candesartan und amlodipin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.